Nautilus Biotechnolgy, Inc.
USD1.86
+0.07 (+3.91%)
CEO
Sujal Patel
IPO Date
2020-08-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.81
Prev. Close
$1.79
Day Low
$1.79
Day High
$1.87
52W Low
$0.62
52W High
$4.31
Market Cap
$0.24B
Volume
0.08M
| 45,000 |
| $2.28 |
| 22 Jun 2026 | Akinsanya Karen | director | A-Award | Acquired | 45,000 | $2.28 |
| 22 Jun 2026 | McIlwain Matthew S | director | A-Award | Acquired | 45,000 | $2.28 |
| 22 Jun 2026 | Epperly Melissa B, | director | A-Award | Acquired | 45,000 | $2.28 |
| 4 Jun 2026 | AH Equity Partners Bio II, L.L.C. | 10 percent owner | S-Sale | Disposed | 4,615,974 | $2.35 |
| 4 Jun 2026 | AH Equity Partners Bio II, L.L.C. | 10 percent owner | S-Sale | Disposed | 384,026 | $2.35 |
| 4 Mar 2026 | Patel Sujal M | director, 10 percent owner, officer: CEO, President, and Secretary | P-Purchase | Acquired | 25,000 | $2.61 |
| 4 Mar 2026 | Mowry Anna | CFO and Treasurer | A-Award | Acquired | 160,000 | $2.32 |
| 4 Mar 2026 | Mallick Parag | director, 10 percent owner, officer: Chief Scientist | A-Award | Acquired | 280,000 | $2.32 |